Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade
Publication
, Journal Article
Newby, LK; Christenson, RH; Ohman, EM; Armstrong, PW; Harrington, RA; White, HD; Irl, C; Califf, RM; Topol, EJ
Published in: CIRCULATION
October 31, 2000
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
589 / 589
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., Christenson, R. H., Ohman, E. M., Armstrong, P. W., Harrington, R. A., White, H. D., … Topol, E. J. (2000). Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade. CIRCULATION, 102(18), 589–589.
Newby, L. K., R. H. Christenson, E. M. Ohman, P. W. Armstrong, R. A. Harrington, H. D. White, C. Irl, R. M. Califf, and E. J. Topol. “Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade.” CIRCULATION 102, no. 18 (October 31, 2000): 589–589.
Newby LK, Christenson RH, Ohman EM, Armstrong PW, Harrington RA, White HD, et al. Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade. CIRCULATION. 2000 Oct 31;102(18):589–589.
Newby, L. K., et al. “Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2000, pp. 589–589.
Newby LK, Christenson RH, Ohman EM, Armstrong PW, Harrington RA, White HD, Irl C, Califf RM, Topol EJ. Conversion of high-risk acute coronary syndromes to low(ER) risk via the use of troponin and platelet glycoprotein IIb/IIIa blockade. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000 Oct 31;102(18):589–589.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
589 / 589
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology